Shutterstock
It’s early days yet. But here’s what we know so far.
If authorized, molnupiravir could be a key oral treatment to help keep COVID-19 patients out of the hospital.
Plyushkin/iStock via Getty Images Plus
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Shutterstock
We’ve made a few mistakes in the past two years, when it comes to developing COVID drugs. Some were obvious and could have easily been avoided.
Shutterstock
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.